Pow.Bio unlocks the economic viability of sustainable biomade products by significantly lowering the high costs of biomanufacturing. Synthetic biology—an emerging field that combines biology, engineering, computer science, and chemistry—enables the design of new biological systems or the reprogramming of existing ones to produce materials, biofuels, medicines, and food ingredients. With the potential to become a $4 trillion market by 2030, its impact hinges on cost-competitive production. As long as biomaterials remain more expensive than petrochemical or animal-based alternatives, only high-end applications will be viable—limiting the scale and sustainability of this transformative technology.
Pow.Bio is revolutionizing biomanufacturing through AI-driven continuous fermentation. Their dual-chamber system separates microbial growth from production, enhancing efficiency and reducing contamination risks. This approach boosts productivity by 2–5 times and cuts costs by up to 70% compared to traditional methods.
Their Alameda facility showcases this technology, enabling rapid scale-up from lab to commercial production across various industries, including food.